Related Experiment Videos

Anophthalmia in an infant of parents using LSD

Annals of Ophthalmology
|December 1, 1980
PubMed

Insights

Unilateral anophthalmia, a rare congenital defect, was observed in an infant whose parents used lysergic acid diethylamide (LSD) before and during pregnancy. This case suggests a potential link between LSD exposure and anophthalmia, warranting further investigation into drug-related birth defects.

Area of Science:

  • Teratology
  • Developmental Biology
  • Pharmacology

Background:

  • Congenital abnormalities require thorough etiological investigation.
  • Lysergic acid diethylamide (LSD) is a potent psychoactive drug with known potential risks during pregnancy.
  • Identifying environmental factors contributing to birth defects is crucial for public health.

Observation:

  • A case of unilateral anophthalmia (absence of one eye) was documented in a newborn infant.
  • The infant presented with normal chromosomal studies.
  • The infant's parents reported LSD use prior to and during the pregnancy.

Findings:

  • The observed unilateral anophthalmia in the infant is not a commonly recognized defect associated with LSD.
  • The absence of other typical LSD-related fetal abnormalities in this case highlights the unique presentation.
  • This case suggests a potential, previously unreported association between LSD exposure and anophthalmia.

Implications:

  • Anophthalmia may represent a novel drug-related congenital defect.
  • Comprehensive parental drug histories are essential for diagnosing congenital abnormalities.
  • Further research is needed to confirm the link between LSD and anophthalmia and to explore other potential drug-induced defects.

Related Concept Videos